We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 0QQD market cap is 23.82B. The company's latest EPS is USD 4.9000 and P/E is 22.55.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.98B | 7.02B | 7.84B | 6.94B | 7.39B |
| Operating Income | 1.14B | -87.8M | 780.1M | 696.3M | 1.28B |
| Net Income | 1.13B | -138.9M | 401.6M | 231.4M | 1.02B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 24.64B | 24.42B | 23.46B | 21.07B | 21.5B |
| Total Liabilities | 12.25B | 12.22B | 10.79B | 9.04B | 9.01B |
| Total Equity | 12.39B | 12.2B | 12.67B | 12.03B | 12.49B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.59B | 1.2B | 1.5B | 1.28B | 1.58B |
| Investing | -729.3M | -613.8M | -503.6M | -529.2M | -778.9M |
| Financing | -779.9M | -421.8M | -1.31B | -843.8M | -763.5M |
| Market Cap | 23.82B |
| Price to Earnings Ratio | 22.55 |
| Price to Sales Ratio | 3.12 |
| Price to Cash Ratio | 55.54 |
| Price to Book Ratio | 1.85 |
| Dividend Yield | - |
| Shares Outstanding | 208.98M |
| Average Volume (1 week) | 35 |
| Average Volume (1 Month) | 28 |
| 52 Week Change | 0.00% |
| 52 Week High | 114.00 |
| 52 Week Low | 114.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Zimmer Biomet Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.zimmerbiomet.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
